Gastric Volvulus Treatment Market Report 2026

Gastric Volvulus Treatment Market Overview

• Gastric Volvulus Treatment market size has reached to $28.86 billion in 2025 • Expected to grow to $39.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Growing Geriatric Demographics Fueling Advancements In The Gastric Volvulus Treatment Market • Market Trend: Product Innovation In Gastric Volvulus Treatment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastric Volvulus Treatment Market?

Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is usually simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect. The main types of gastric volvulus treatment are organo-axial and mesentero-axial volvulus. Organo-axial volvulus refers to a symptom that occurs when the abdomen spins 180 degrees around its long axis and suffers from organo-axial volvulus. It is available in various treatment types, including medication and surgery, and in various routes of administration, including oral and parenteral. The distribution channels are hospital pharmacies and retail pharmacies, and are used by hospitals, home healthcare, specialty clinics and others.

What Is The Gastric Volvulus Treatment Market Growth Forecast?

The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $39.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growth in minimally invasive surgery, improved emergency response systems, adoption of advanced imaging, expansion of specialty surgical centers, increased clinical awareness. Major trends in the forecast period include rising preference for surgical intervention, increased adoption of minimally invasive procedures, improved emergency diagnosis and management, expansion of specialized surgical care, focus on rapid treatment to reduce mortality.

Global Gastric Volvulus Treatment Market Segmentation

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus 2) By Treatment Type: Medication, Surgery 3) By Route Of Administration: Oral, Parenteral 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy 5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy 2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques

What Is The Driver Of The Gastric Volvulus Treatment Market?

A rising geriatric population is expected to propel the growth of the gastric volvulus treatment market going forward. The geriatric population refers to older adults 65 years and beyond. The geriatric population suffers from various diseases due to low immunity and age. Gastric volvulus occurs in older adults over the age of 50. Hence, the rise in the geriatric population is expected to propel the market. For instance, in January 2024, according to the statistics published by the Population Reference Bureau (PRB), a US-based nonprofit organization, it is anticipated that the number of Americans 65 and older will climb from 58 million in 2022 to 82 million in 2050 (a 47% increase) and that their proportion of the overall population will increase from 17% to 23%. Therefore, rising geriatric populations are driving the gastric volvulus treatment industry.

Key Players In The Global Gastric Volvulus Treatment Market

Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.

Global Gastric Volvulus Treatment Market Trends and Insights

Major companies operating in the gastric volvulus treatment market are focusing on developing innovative solutions, such as next-generation oral immunomodulatory therapies, to meet the rising demand for advanced treatment options that improve long-term disease control and patient quality of life. These orally administered therapies target inflammatory and immune-driven mechanisms, offering a more convenient and targeted alternative compared with traditional systemic treatments that may carry higher side-effect risks and require more intensive management. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator for people with moderate to severe active ulcerative colitis (UC). VELSIPITY's official suggested dosage is 2 mg. ELSIPITY allows adults with moderately to severely active UC to achieve steroid-free resolution with an oral, once-daily pill that has a positive benefit-risk profile. The FDA's approval of VELSIPITY today marks an important turning point for UC patients who require novel therapies for this long-term illness and are ready to begin advanced therapy.

What Are Latest Mergers And Acquisitions In The Gastric Volvulus Treatment Market?

In January 2024, Olympus Corporation, a Japan-based MedTech company specializing in imaging systems, endoscopes, and therapeutic solutions, acquired Taewoong Medical Co., Ltd. for approximately US$ 370 million. With this acquisition, Olympus sought to strengthen and diversify its GI Endotherapy product portfolio by integrating Taewoong’s advanced metallic stent technologies. Taewoong Medical, a China-based company, manufactures a range of gastrointestinal metallic stents designed for the biliary tract, esophagus, colon, and duodenum that enable minimally invasive interventions for GI strictures and obstructions.

Regional Outlook

North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastric Volvulus Treatment Market?

The gastric volvulus treatment market includes revenues earned by entities that perform laparotomy, gastric detorsion, and gastric fixation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastric Volvulus Treatment Market Report 2026?

The gastric volvulus treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastric volvulus treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.